about
Colorectal cancer tumour markers and biomarkers: Recent therapeutic advancesCurrent views on the mechanisms of immune responses to trauma and infectionHost response, obesity, and oral healthHost response, malnutrition and oral diseases. Part 1.Innate immunity gene expression changes in critically ill patients with sepsis and disease-related malnutrition.Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.Host response, malnutrition and oral diseases. Part 2.The immune response to surgery and infection.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.Disorders of nutritional status in sepsis - facts and myths.Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progressionImmune disorders in anorexia.Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome.The diagnostic value of early cytokine response in patients after major trauma - preliminary report.The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgeryInterleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgerySystematic mediastinal lymphadenectomy does not increase postoperative immune response after major lung resectionsApoptosis in lymphocytes of pancreatic cancer patients: influence of preoperative enteral immunonutrition and extensive surgeryMediastinal lymphadenectomy influences postoperative immune response after lung cancer surgery
P50
Q26768427-C1892193-FB00-45B0-9247-F10CD406B6CCQ26777986-24267E5A-34F9-47CC-B825-43AAA08655CCQ26777989-209CDE3F-BF9E-44D6-AAF8-862D1068ECFCQ35631699-8709EAB5-441E-42DB-8C29-DBB599F2236EQ36305612-FEFDD6B3-7E2D-41CA-B964-B4A2F5FDAA8AQ37739809-EAF3B716-728A-4B38-8092-162A81CCEF05Q38544032-9531A63F-1667-41A3-9159-E74986B460D3Q38544034-7B6AE8BA-F3EE-450C-BFC8-37A310B33C25Q38815842-35FF745A-8E58-46F1-8CA3-BA602A96544EQ39431573-2EBD2A74-BA6E-4806-9E87-54DB596949ADQ40923346-373F9ECF-4C7D-4F91-8E61-228A753F0BCCQ47110268-F1254244-DB2B-4F04-B652-A44A7273B2FEQ48359393-7972FA39-90C8-4397-8944-FF022F582AB0Q55022351-8B70FA17-5F4C-4BAB-862E-FA27A34F3F1AQ78442480-A2CBD912-DBC4-4D41-B638-CE6B00682502Q79817030-D5FA7A73-C92C-4AAC-8031-F3A2E2424504Q81410902-34343F64-B23E-4C56-B902-1E24862628B0Q84699367-3B07D693-4835-455D-A433-F5BC7DB445C6Q84804599-3F9E5E66-AF14-48A7-94A3-7B700752D458
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
Robert Slotwiński
@en
Robert Slotwiński
@nl
type
label
Robert Slotwiński
@en
Robert Slotwiński
@nl
prefLabel
Robert Slotwiński
@en
Robert Slotwiński
@nl
P106
P31
P496
0000-0002-6063-5126